Equine IL-4 from AbD Serotec

Goat Anti-HSPC150 Polyclonal Antibody, Unconjugated from Abcam

Mouse Anti-Human Oct 2 Monoclonal Antibody, Unconjugated, Clone PT2 from ABR-Affinity BioReagents

Mouse Anti-HSV1, HSV2 ICP5 Major Capsid Protein Monoclonal Antibody, Unconjugated, Clone 3B6 from Abcam

Mouse Anti-Aequorin Monoclonal Antibody, Unconjugated, Clone 2Q2147 from Abcam

(Date:12/4/2009)By measuring the total gene activity in organs relevant for coronary artery disease (CAD), scientists at the Swedish medical university Karolinska Institutet have identified a module of genes that is

(Date:12/4/2009)Using a new mathematical model of heart cells, University of Iowa investigators have shown how activation of a critical enzyme, calmodulin kinase II (CaM kinase), disrupts the electrical activity of h

(Date:12/3/2009)Our ability to learn new information and adapt to changes in our daily environment, as well as to retain lifelong memories, appears to lie in the minute junctions where nerve cells communicate, accord

...known as HACNS1, that may have contributed to the ...nd possibly also modifications in the ankle or foo... to a paper published in Science on Sept. 5, 200...of the existence of human-specific gene enhancers,.... , Dr. Shyam Prabhakar, first author of the pa...

...f Cincinnati (UC) implicates the primary chemical ... risk factor for metabolic syndrome and its conseq...n fat tissues, the UC team found that BPA suppress...e for regulating insulin sensitivity in the body a...metabolic syndrome. , Metabolic syndrome is a co...

... A variety of organismsfrom bacteria and fungi to ...he timing and duration of fundamental biological p...apt and survive, even under fluctuating environmen...nces have been made to understand the molecular ba...odifications in cellular physiology and organismal...

(Date:12/2/2009)NEW YORK, Dec. 2 Reportlinker.com announces that a new market research report is available in its catalogue: ,, Drug Discovery Technologies - A Global Update of Market Trends & Opportunities ,,

(Date:12/2/2009)COPENHAGEN, Dec. 2 The world,s first concept demonstration tires made with BioIsoprene technology, a breakthrough alternative to replace a petrochemically produced ingredient in the manufacture of

(Date:12/2/2009)CALGARY, Dec. 2 /PRNewswire-FirstCall/ - Oncolytics Biotech Inc. ("Oncolytics" or the "Company") (TSX:ONC; NASDAQ: ONCY ) announced today that in connection with its previously announced unit offering

(Date:12/2/2009)LELYSTAD, The Netherlands, December 2 Pepscan Holding NV,the Netherlands based biotechnology company focusing on protein mimicking,technology for the generation of immune therapeutics today announced